These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17158545)

  • 1. Molecular biology of renal cell cancer and the identification of therapeutic targets.
    Iliopoulos O
    J Clin Oncol; 2006 Dec; 24(35):5593-600. PubMed ID: 17158545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
    Schanza LM; Seles M; Stotz M; Fosselteder J; Hutterer GC; Pichler M; Stiegelbauer V
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of nuclear factor kappa B in renal cell carcinoma.
    Morais C; Gobe G; Johnson DW; Healy H
    Int J Biochem Cell Biol; 2011 Nov; 43(11):1537-49. PubMed ID: 21854869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor suppressor gene VHL, hypoxia inducible factor, and renal cell carcinoma].
    Zhang YT; Chen N; Zeng H; Zhou Q
    Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):562-4. PubMed ID: 17134554
    [No Abstract]   [Full Text] [Related]  

  • 5. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
    Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von hippel-lindau: a tumor suppressor links microtubules to ciliogenesis and cancer development.
    Kuehn EW; Walz G; Benzing T
    Cancer Res; 2007 May; 67(10):4537-40. PubMed ID: 17510376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional significance of erythropoietin in renal cell carcinoma.
    Morais C; Johnson DW; Vesey DA; Gobe GC
    BMC Cancer; 2013 Jan; 13():14. PubMed ID: 23305401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B.
    Krishnamachary B; Zagzag D; Nagasawa H; Rainey K; Okuyama H; Baek JH; Semenza GL
    Cancer Res; 2006 Mar; 66(5):2725-31. PubMed ID: 16510593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular biology of the clear cell renal cell carcinoma: principles for a selective treatment].
    Grande Pulido E; Martín Centeno A; Maroto Rey P; Solsona Narbón E
    Actas Urol Esp; 2007 Mar; 31(3):233-43. PubMed ID: 17658151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Hippel-Lindau tumor suppressor protein regulates the assembly of intercellular junctions in renal cancer cells through hypoxia-inducible factor-independent mechanisms.
    Calzada MJ; Esteban MA; Feijoo-Cuaresma M; Castellanos MC; Naranjo-Suárez S; Temes E; Méndez F; Yánez-Mo M; Ohh M; Landázuri MO
    Cancer Res; 2006 Feb; 66(3):1553-60. PubMed ID: 16452212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK kinases promote invasiveness in VHL-mediated renal cell carcinoma by a suppressor of cytokine signaling-regulated, HIF-independent mechanism.
    Wu KL; Miao H; Khan S
    Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1836-46. PubMed ID: 17898043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the biology of renal cell carcinoma.
    Li L; Kaelin WG
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):667-86. PubMed ID: 21763962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cilium formation requires von hippel-lindau gene function in renal-derived cells.
    Lutz MS; Burk RD
    Cancer Res; 2006 Jul; 66(14):6903-7. PubMed ID: 16849532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
    Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER
    Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gramicidin A induces metabolic dysfunction and energy depletion leading to cell death in renal cell carcinoma cells.
    David JM; Owens TA; Barwe SP; Rajasekaran AK
    Mol Cancer Ther; 2013 Nov; 12(11):2296-307. PubMed ID: 24006494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.
    Pan J; Mestas J; Burdick MD; Phillips RJ; Thomas GV; Reckamp K; Belperio JA; Strieter RM
    Mol Cancer; 2006 Nov; 5():56. PubMed ID: 17083723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetics of familial renal cell carcinoma syndromes.
    Cohen D; Zhou M
    Clin Lab Med; 2005 Jun; 25(2):259-77. PubMed ID: 15848736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma.
    Petrella BL; Lohi J; Brinckerhoff CE
    Oncogene; 2005 Feb; 24(6):1043-52. PubMed ID: 15592504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for renal cancer.
    Haviv YS; Curiel DT
    Contrib Nephrol; 2008; 159():135-150. PubMed ID: 18391590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma.
    Parker AS; Cheville JC; Lohse CM; Igel T; Leibovich BC; Blute ML
    Urology; 2005 Jun; 65(6):1090-5. PubMed ID: 15893810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.